DNA jolt for wrinkles? new trial tests PIEZO-101
NCT ID NCT07671027
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new treatment called PIEZO-101, a DNA-based biostimulator, for skin aging in the knee and décolleté areas. It is given by injection followed by a mild electric pulse (electroporation) to help it enter skin cells. The trial will enroll 8 healthy women aged 40-65 and focus mainly on safety and how the skin responds.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PIEZO-101 (a plasmid DNA biostimulator)
What this could lead to
If it works, this could point toward a non-surgical treatment for skin aging and wrinkles.
What could go wrong
This is a very early, first-in-human trial with only 8 participants. It is designed mainly to check safety, not effectiveness, and may not lead to a real treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.